Predicting the risk of prostate cancer on biopsy
Ebell, M.H.
American Family Physician 72(6): 1091-1092
2005
ISSN/ISBN: 0002-838X PMID: 16190506 Document Number: 589447
Document emailed within 1 workday
Related Documents
Ide, H.; Yasuda, M.; Nishio, K.; Saito, K.; Isotani, S.; Kamiyama, Y.; Muto, S.; Horie, S. 2008: Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels Anticancer Research 28(4c): 2487-2492Zhu, X-Dong.; Zheng, A.; Wang, Z-Qian.; Shao, Q. 2018: Prostate Cancer Prevention Trial risk calculator for evaluating the risk of prostate cancer in the high-risk Chinese population Zhonghua Nan Ke Xue 24(2): 142-146
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Patel, P.; Nayak, J.G.; Biljetina, Z.; Donnelly, B.; Trpkov, K. 2015: Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy Canadian Journal of Urology 22(6): 8056-8062
Miyamoto, S.; Jimbo, H.; Totsuka, Y.; Mashimo, T.; Umeyama, T.; Uehara, H.; Shinozaki, T. 1995: Change in serum prostate specific antigen values in men who had no evidence of prostate cancer on initial biopsy Hinyokika Kiyo. Acta Urologica Japonica 41(10): 767-770
Liang, J.; Zhao, X.-Z.; Shi, J.-Y.; Qiu, X.-F.; Zhang, Q.; Zhuang, J.-L.; Wang, W.; Deng, Y.-M.; Huang, H.-F.; Zhang, C.-W.; Guo, H.-Q. 2019: Combination of serum PSA assay, multi-parametric MRi and targeted prostate biopsy for prostate cancer screening in Nanjing Zhonghua Nan Ke Xue 25(9): 815-822
Qu, H.-W.; Liu, H.; Cui, Z.-L.; Jin, X.-B.; Zhao, Y.; Wang, M.-W.; Song, W.; Zhang, X.-J. 2016: Focusing on MRI-suspected lesions in targeted transrectal prostate biopsy guided by MRI-TRUS fusion imaging for the diagnosis of prostate cancer Zhonghua Nan Ke Xue 22(9): 782-786
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Schalken, J.A. 1991: Molecular methods for predicting the metastatic potential of prostate cancer Cancer Surveys 11: 43-54
Habib, F.K.; Chisholm, G.D. 1984: Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate Archivos Espanoles de Urologia 37(Suppl 2): 751-759
Xiao, W.-j.; Ye, D.-w.; Yao, X.-d.; Zhang, S.-l.; Dai, B.; Wang, Z.-f.; Wang, J.; Zhang, H.-l.; Shen, Y.-j.; Zhu, Y.; Zhu, Y.-p.; Shi, G.-h.; Ma, C.-g.; Qin, X.-j.; Lin, G.-w. 2010: Establishment of regression model predicting the probability of the capsular penetration of prostate cancer Zhonghua Yi Xue Za Zhi 90(42): 2976-2979
Murray, N.P.; Aedo, S.óc.; Fuentealba, C.; Reyes, E.; Minzer, S.; Salazar, A.íb. 2019: Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer Archivos Espanoles de Urologia 72(5): 471-482
Spaander, P.J.; Mostofi, K.; Blom, J. 1990: Biopsy techniques and cytology in prostate cancer Progress in Clinical and Biological Research 357: 157-158
Hara, T.; Yokoyama, S.; Tsutahara, K.; Fukuhara, S.; Mori, N.; Yamaguchi, S.; Maejima, S.; Yoshida, S.; Adachi, S. 2005: Repeat biopsy of the suspicious prostate cancer: especially the usefulness of MRI Hinyokika Kiyo. Acta Urologica Japonica 51(6): 373-376
Wang, H.; Zhou, X.; Chen, S.; Zhu, C.; Yu, X. 2004: Investigation of infection risk and the value of antibiotic prophylaxis during transrectal biopsy of the prostate by endotoxin determination Zhonghua Nan Ke Xue 10(7): 496-498; 502
Martínez-Sarmiento, M.; Pérez-Ardavin, J.; Monserrat-Monfort, J.J.é; Sánchez-González, J.é V.; Sopena-Novales, P.; Bello-Arqués, P.; Olivas-Arroyo, C.; Vera-Donoso, C.és.D.; Boronat-Tormo, F. 2019: Sentinel lymph node selective biopsy in prostate cancer Archivos Espanoles de Urologia 72(8): 842-850
Fiset, P.O.; Aprikian, A.; Brimo, F. 2013: Length of prostate biopsy cores: does it impact cancer detection? Canadian Journal of Urology 20(4): 6848-6853
Derakhshani, P.; Neubauer, S.; Braun, M.; Zumbé, J.; Heidenreich, A.; Engelmann, U. 1998: Cryoablation of localized prostate cancer. Experience in 48 cases, PSA and biopsy results European Urology 34(3): 181-187
Novikov, R.V.; Novikov, S.N.; Kanaev, S.V.; Iliin, N.D.; Klimashevsky, V.F.; Artemieva, A.S.; Ivantsov, A.O.; Reva, S.A. 2016: Clinical value of transperineal saturation biopsy in patients with suspicious for prostate cancer Voprosy Onkologii 62(2): 290-295
Ojewola, R.W.; Tijani, K.H.; Jeje, E.A.; Anunobi, C.C.; Ogunjimi, M.A.; Ezenwa, E.V.; Ogundiniyi, O.S. 2012: Detection of prostate cancer: comparison of cancer detection rates of sextant and extended ten-core biopsy protocols Nigerian Postgraduate Medical Journal 19(3): 137-142